🇺🇸 FDA
Patent

US 9186365

Antiangiogenic small molecules and methods of use

granted A61KA61K31/10A61K31/135

Quick answer

US patent 9186365 (Antiangiogenic small molecules and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/10, A61K31/135, A61K31/285, A61K31/4015